On November 4, Travelers rose 3.18% in Pre-Market Trading to $406.65 per share, with turnover of $3.2674 million.
The main catalyst in focus is the company’s stronger-than-expected third-quarter results, followed by a series of analyst target-price updates after the report.
Travelers reported third-quarter core EPS of $9.18 on revenue of $12.41 billion, ahead of consensus expectations near $7.4 per share and about $11.38 billion in revenue. Net income was $1.917 billion, the combined ratio was 86.8%, and underwriting profitability remained strong. After the release, several firms raised targets, including Morgan Stanley to $350 from $330, Jefferies to $365 from $351, Truist to $435 from $425, and Roth Capital to $460 from $425, although Evercore later cut its target to $342 from $372. The mixed but active post-earnings revisions help explain why the stock is drawing renewed attention.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments